-
CDRD, Dalhousie, IWK establish new Atlantic research node
VANCOUVER and HALIFAX | The Centre for Drug Research and Development, Canada's national drug development and commercialization centre, and its partners Dalhousie University and the IWK Health Centre, have established a new CDRD Atlantic Research Node. -
Novel program for early-onset morbid obesity licensed to Pfizer
MONTREAL | The Institute for Research in Immunology and Cancer - Commercialization of Research and its host institution, the Université de Montréal, have licensed a novel early-onset morbid obesity pre-clinical program to Pfizer. The program was developed at the Institute for Research in Immunology and Cancer.